Announcement

Beaufort Joins Avoca Quality Consortium to Provide Thought Leadership in Advancing Clinical Trial Quality for Sponsors

Beaufort is pleased to announce that it has joined Avoca Quality Consortium, a collaboration of health and life science industry professionals dedicated to elevating awareness and promoting expertise around the practice of clinical trial quality.

“We are excited to be part of an organization that is dedicated to having a positive impact on achieving clinical trial excellence through the advancement of robust clinical quality solutions,” said John R. Wilson Jr., Ph.D., MPH, Senior Vice President, Global Quality Solutions. “Our team looks forward to actively participating in the Avoca community and is eager to help demonstrate the value and impact of a third-party clinical quality evaluation and assessment program.”

Beaufort’s participation in Avoca comes at a time when the FDA is applying increasing pressure on sponsors to validate the work of their CROs. Through Beaufort’s Independent Clinical Quality Evaluation (ICQE) services, we help sponsors ensure CROs and third-party vendors are performing according to expectations and mandates by the FDA and other regulatory bodies. Our solutions provide sponsors an added layer of security and protection for their clinical trials with services that focus on data integrity, human subject protection, risk assessment and mitigation, and regulatory success.

“Avoca provides a great platform to connect with like-minded professionals, as well as share our best practices, innovative tools, and practical solutions through their working groups, advisory boards, and forums,” said Dr. Wilson.

Read more about Beaufort’s Independent Clinical Quality Evaluation services and how we have helped some of the world’s leading health science companies.

View all news & insights